Natixis Advisors LLC Boosts Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Natixis Advisors LLC raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 29.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 59,253 shares of the biopharmaceutical company’s stock after acquiring an additional 13,616 shares during the quarter. Natixis Advisors LLC’s holdings […]
Natixis Advisors LLC raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 29.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 59,253 shares of the biopharmaceutical company’s stock after acquiring an additional 13,616 shares during the quarter. Natixis Advisors LLC’s holdings […]
